Meyka AI API is live for developers.Start building.
Advertisement
Natera, Inc.

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NTRANASDAQ
HealthcareMedical - Diagnostics & Research
$215.31
$6.79(3.06%)
U.S. Market opens in 53h 11m
Advertisement

Natera, Inc. (NTRA)

Meyka AI Score

Z

Key Financials

Market Cap30.8B
P/E Ratio-134.50
EPS (TTM)$-1.62
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$218.04
3 Months$221.91
1 Year Target$280.34

NTRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Natera, Inc. (NTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -134.50 and a market capitalization of 30.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.06%
5-Day Change
0.16%
1-Month Change
4.13%
3-Month Change
9.22%
6-Month Change
-11.96%
Year-to-Date (YTD) Change
-6.02%
1-Year Change
30.09%
3-Year Change
350.91%
5-Year Change
110.74%
All-Time (Max) Change
1096.17%

Contact Information

650 249 9090
13011 McCallen Pass Building A, Austin, CA, 78753

Company Facts

4,424 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions